Correlation Between Lyxor 1 and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Lyxor 1 and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyxor 1 and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyxor 1 and Novo Nordisk AS, you can compare the effects of market volatilities on Lyxor 1 and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyxor 1 with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyxor 1 and Novo Nordisk.
Diversification Opportunities for Lyxor 1 and Novo Nordisk
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lyxor and Novo is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Lyxor 1 and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Lyxor 1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyxor 1 are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Lyxor 1 i.e., Lyxor 1 and Novo Nordisk go up and down completely randomly.
Pair Corralation between Lyxor 1 and Novo Nordisk
Assuming the 90 days trading horizon Lyxor 1 is expected to generate 0.36 times more return on investment than Novo Nordisk. However, Lyxor 1 is 2.8 times less risky than Novo Nordisk. It trades about 0.13 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.13 per unit of risk. If you would invest 2,481 in Lyxor 1 on December 29, 2024 and sell it today you would earn a total of 204.00 from holding Lyxor 1 or generate 8.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Lyxor 1 vs. Novo Nordisk AS
Performance |
Timeline |
Lyxor 1 |
Novo Nordisk AS |
Lyxor 1 and Novo Nordisk Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lyxor 1 and Novo Nordisk
The main advantage of trading using opposite Lyxor 1 and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyxor 1 position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.Lyxor 1 vs. Lyxor Fed Funds | Lyxor 1 vs. Lyxor BofAML USD | Lyxor 1 vs. Lyxor Index Fund | Lyxor 1 vs. Lyxor 1 TecDAX |
Novo Nordisk vs. National Retail Properties | Novo Nordisk vs. Globe Trade Centre | Novo Nordisk vs. TRADELINK ELECTRON | Novo Nordisk vs. Atresmedia Corporacin de |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |